Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,501.24
(
0.00%
)
US TECH 100
28,308.00
(
-1.68%
)
Dow Jones
50,063.46
(
0.00%
)
Brent Oil
105.36
(
1.13%
)
Bitcoin
80,100.63
(
-1.18%
)
News Focus
News Focus
Post# of 257566
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122982
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 136126

Wednesday, 05/02/2012 9:45:56 PM

Wednesday, May 02, 2012 9:45:56 PM

Post# of 257566
PFE’s new 2012 non-GAAP EPS guidance after adjusting for the divestiture of the Nutrition business (which is now accounted for as a discontinued operation) is $2.14-2.24:

http://finance.yahoo.com/news/Pfizer-Reports-First-Quarter-bwtmp-2104763031.html?x=0&.v=1&c=1

The old guidance (including the Nutrition business) was $2.20-2.30.

The rest of the commentary in #msg-71524448 re PFE’s valuation and status as a beneficiary of The Global Demographic Tailwind is unchanged.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today